ONWARD MEDICAL (ONWD.BR) Fundamental Analysis & Valuation

EBR:ONWD • NL0015000HT4

3.875 EUR
+0.02 (+0.52%)
Last: Mar 10, 2026, 12:13 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ONWD.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ONWD. ONWD was compared to 65 industry peers in the Health Care Equipment & Supplies industry. While ONWD seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ONWD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. ONWD.BR Profitability Analysis

1.1 Basic Checks

  • In the past year ONWD has reported negative net income.
  • In the past year ONWD has reported a negative cash flow from operations.
  • In the past 5 years ONWD always reported negative net income.
  • In the past 5 years ONWD always reported negative operating cash flow.
ONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of ONWD (-67.68%) is worse than 87.69% of its industry peers.
  • The Return On Equity of ONWD (-137.73%) is worse than 81.54% of its industry peers.
Industry RankSector Rank
ROA -67.68%
ROE -137.73%
ROIC N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONWD.BR Yearly ROA, ROE, ROICONWD.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

  • ONWD has a Gross Margin of 77.16%. This is amongst the best in the industry. ONWD outperforms 89.23% of its industry peers.
  • ONWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONWD.BR Yearly Profit, Operating, Gross MarginsONWD.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ONWD.BR Health Analysis

2.1 Basic Checks

  • ONWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ONWD has more shares outstanding
  • Compared to 5 years ago, ONWD has more shares outstanding
  • The debt/assets ratio for ONWD has been reduced compared to a year ago.
ONWD.BR Yearly Shares OutstandingONWD.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ONWD.BR Yearly Total Debt VS Total AssetsONWD.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • ONWD has an Altman-Z score of -1.67. This is a bad value and indicates that ONWD is not financially healthy and even has some risk of bankruptcy.
  • ONWD has a worse Altman-Z score (-1.67) than 83.08% of its industry peers.
  • A Debt/Equity ratio of 0.52 indicates that ONWD is somewhat dependend on debt financing.
  • ONWD has a Debt to Equity ratio (0.52) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -1.67
ROIC/WACCN/A
WACC7.49%
ONWD.BR Yearly LT Debt VS Equity VS FCFONWD.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.34 indicates that ONWD has no problem at all paying its short term obligations.
  • ONWD has a Current ratio of 4.34. This is amongst the best in the industry. ONWD outperforms 95.38% of its industry peers.
  • A Quick Ratio of 4.30 indicates that ONWD has no problem at all paying its short term obligations.
  • ONWD has a Quick ratio of 4.30. This is amongst the best in the industry. ONWD outperforms 98.46% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 4.3
ONWD.BR Yearly Current Assets VS Current LiabilitesONWD.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ONWD.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.69% over the past year.
  • The Revenue has grown by 236.76% in the past year. This is a very strong growth!
EPS 1Y (TTM)20.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.47%
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ONWD will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.03% on average per year.
  • ONWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 148.02% yearly.
EPS Next Y8.5%
EPS Next 2Y5.76%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue Next Year313%
Revenue Next 2Y226.6%
Revenue Next 3Y218.91%
Revenue Next 5Y148.02%

3.3 Evolution

ONWD.BR Yearly Revenue VS EstimatesONWD.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
ONWD.BR Yearly EPS VS EstimatesONWD.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. ONWD.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ONWD. In the last year negative earnings were reported.
  • Also next year ONWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONWD.BR Price Earnings VS Forward Price EarningsONWD.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONWD.BR Per share dataONWD.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ONWD's earnings are expected to grow with 12.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.76%
EPS Next 3Y12.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ONWD.BR Dividend Analysis

5.1 Amount

  • ONWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ONWD.BR Fundamentals: All Metrics, Ratios and Statistics

ONWARD MEDICAL

EBR:ONWD (3/10/2026, 12:13:14 PM)

3.875

+0.02 (+0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-24
Earnings (Next)03-30
Inst Owners27.61%
Inst Owner ChangeN/A
Ins Owners9.81%
Ins Owner ChangeN/A
Market Cap217.04M
Revenue(TTM)1.11M
Net Income(TTM)-38.18M
Analysts87.27
Price Target10.42 (168.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.17%
Revenue NY rev (3m)-9.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 195.18
P/FCF N/A
P/OCF N/A
P/B 7.83
P/tB 11.75
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.02
BVpS0.49
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -67.68%
ROE -137.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.16%
FCFM N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.34%
Cap/Sales 31.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.34
Quick Ratio 4.3
Altman-Z -1.67
F-Score6
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)43.86%
Cap/Depr(5y)180.36%
Cap/Sales(3y)362.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.47%
EPS Next Y8.5%
EPS Next 2Y5.76%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year313%
Revenue Next 2Y226.6%
Revenue Next 3Y218.91%
Revenue Next 5Y148.02%
EBIT growth 1Y0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-22.55%
EBIT Next 3Y4.97%
EBIT Next 5YN/A
FCF growth 1Y-9.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.94%
OCF growth 3YN/A
OCF growth 5YN/A

ONWARD MEDICAL / ONWD.BR FAQ

Can you provide the ChartMill fundamental rating for ONWARD MEDICAL?

ChartMill assigns a fundamental rating of 2 / 10 to ONWD.BR.


What is the valuation status of ONWARD MEDICAL (ONWD.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to ONWARD MEDICAL (ONWD.BR). This can be considered as Overvalued.


What is the profitability of ONWD stock?

ONWARD MEDICAL (ONWD.BR) has a profitability rating of 1 / 10.


Can you provide the financial health for ONWD stock?

The financial health rating of ONWARD MEDICAL (ONWD.BR) is 4 / 10.


Can you provide the expected EPS growth for ONWD stock?

The Earnings per Share (EPS) of ONWARD MEDICAL (ONWD.BR) is expected to grow by 8.5% in the next year.